SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-012167
Filing Date
2024-05-03
Accepted
2024-05-03 16:20:08
Documents
1
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05032024_040502.html 4  
1 form4-05032024_040502.xml 4 7876
  Complete submission text file 0001415889-24-012167.txt   9281
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Walker Neal (Reporting) CIK: 0001604457 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 24913428